Sankar Mohan

Sankar Mohan is a Principal Scientist II at Gilead Sciences, where they have held various senior research positions since 2015. They previously worked as a Senior Research Scientist at AMRI and were a Postdoctoral Fellow at Simon Fraser University, focusing on the design of novel inhibitors relevant to treatments for diabetes, influenza, and tuberculosis. Sankar earned their MSc in Chemistry from R K M Vivekananda College, affiliated with the University of Madras, in 2000.